- Agosto 2024

Ramchand SK, Ghasem-Zadeh A, Hoermann R, et al.

Denosumab prevents bone loss and microarchitectural deterioration in premenopausal women with breast cancer receiving estradiol suppression therapy: a randomized controlled trial

J Clin Oncol 2024 Jul 2:JCO2302309. Epub ahead of print

Simonpietro Marrocco Agosto 2024

Leggi abstract | Scarica ppt

---

Hahn E, Sutradhar R, Paszat L, et al.

Molecular expression assays improve the prediction of local and invasive local recurrence after breast-conserving surgery for ductal carcinoma in situ

J Clin Oncol 2024 Jun 28:JCO2302276. Epub ahead of print

Simonpietro Marrocco Agosto 2024

Leggi abstract | Scarica ppt

---

Katz SJ, Abrahamse P, Furgal A, et al.

Genetic counseling, testing, and family communication into survivorship after diagnosis of breast cancer

J Clin Oncol 2024 Jul 15:JCO2400122. Epub ahead of print

Simonpietro Marrocco Agosto 2024

Leggi abstract | Scarica ppt

---

Matikas A, Möbus V, Greil R, et al.

Tailored dose-dense versus standard adjuvant chemotherapy for high-risk early breast cancer: end-of-study results of the randomized PANTHER trial

J Clin Oncol 2024 Jul 17:JCO2400178. Epub ahead of print

Simonpietro Marrocco Agosto 2024

Leggi abstract | Scarica ppt

---

Salim M, Liu Y, Sorkhei M, et al.

AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial

Nat Med 2024 Jul 8. Epub ahead of print

Simonpietro Marrocco Agosto 2024

Leggi abstract | Scarica ppt

---

Rapp SR, Dressler EV, Brown WM, et al.

Phase III randomized, placebo-controlled clinical trial of donepezil for treatment of cognitive impairment in breast cancer survivors after adjuvant chemotherapy (WF-97116)

J Clin Oncol 2024;42(21):2546-2557

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Stone PC, Minton O, Richardson A, et al.

Methylphenidate versus placebo for treating fatigue in patients with advanced cancer: randomized, double-blind, multicenter, placebo-controlled trial

J Clin Oncol 2024;42(20):2382-2392

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Arecco L, Bruzzone M, Bas R, et al.

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Ann Oncol 2024 Jun 20:S0923-7534(24)00740-3

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Dent R, Cortés J, Pusztai L, et al.

Neoadjuvant pembrolizumab + chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from randomized KEYNOTE-522 study

J Natl Cancer Inst 2024 Jun 24:djae129

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Freedman RA, Heiling HM, Li T, et al.

Neratinib and ado-trastuzumab-emtansine for pre-treated and untreated her2-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022

Ann Oncol 2024 Jul 6:S0923-7534(24)01015-9. Epub ahead of print

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Puklin LS, Ferrucci LM, Harrigan M, et al.

Improving lifestyle behaviors during chemotherapy for breast cancer: the Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) trial

Cancer 2024;130(14):2440-2452

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Blomqvist C, Vehmanen L, Kellokumpu-Lehtinen PL, et al.

Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study

Breast Cancer Res Treat 2024;206(1):57-65

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Debien V, Agostinetto E, Bruzzone M, et al.

The impact of initial tumor response on survival outcomes of patients with HER2-positive advanced breast cancer treated with docetaxel, trastuzumab, and pertuzumab: an exploratory analysis of the CLEOPATRA trial

Clin Breast Cancer 2024;24(5):421-430.e3

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Chung HC, Saada-Bouzid E, Longo F, et al.

Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 study

Cancer 2024 Jun 21. Epub ahead of print

Simonpietro Marrocco Agosto 2024

Leggi abstract

---

Corianò M, Tommasi C, Dinh ATL, et al.

The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study

Breast Cancer Res Treat 2024;206(3):603-614

Simonpietro Marrocco Agosto 2024

Leggi abstract

---